News and Research

Stereotactic body radiation therapy plus chemotherapy improves survival

A clinical trial that combined stereotactic body radiation therapy (SBRT) with a specific chemotherapy regimen more than doubled survival rates for certain patients with stage 4 lung cancer, according to a new report in the Journal of Clinical Oncology 

 

Lung Cancer and Radiation Therapy - Updates in Cancer Care Symposium Presentation

Dr Lao presented at the Updates in Cancer Care Symposium on 15th November, held on the Mercy Hospital site.
This presentation covered the use of Stereotactic Ablative Radiation Therapy in the treatment of Lung Cancer.

 

Patterns of Nodal Relapse when treated with SBRT

Incidental Prophylactic Nodal Irradiation and Patterns of Nodal Relapse in Inoperable Early Stage NSCLC Patients Treated With SBRT

 

Stereotactic radiation therapy in early stage NSCLC

Stereotactic body radiation therapy can be an effective treatment for early stage non-small cell lung cancer

 

39677.jpg

New radiation therapy shows promise in lung cancer

Aiming powerful beams of radiation precisely at tumors helped control their growth and helped people with early stage but inoperable lung cancer live longer

 

Multidisciplinary Lung Metastases Clinic

Research into the value of multidisciplinary discussions with regard to patient care

 

Combined Modality Therapy for Stage I-II DLBCL

Combined Modality Therapy for Stage I-II Diff use Large B-Cell Lymphoma Provides Excellent Local Control and Clinical Outcome in the Rituximab Era

 

Pattern of failure in stage I-II Hodgkin Lymphoma patients treated with CMT

Implications of partial nodal region coverage and the need for adjacent uninvolved nodal region coverage

 

Radiation-induced vertebral compression fracture following spine stereotactic radiosurgery

Spine stereotactic radiosurgery (SRS) is increasingly being used to treat metastatic spinal tumors. As the experience matures, high rates of vertebral  compression fracture (VCF) are being observed. 
What is unknown is the mechanism of action; it has been postulated but not confirmed that radiation itself is a contributing factor. This case report describes 2 patients who were treated with spine SRS who subsequently developed signal changes on MRI consistent with tumor progression and VCF.

 

Percutaneous spine stabilisation prior to stereotactic radiosurgery for high risk spinal metastases

New, or progression of existing, vertebral compression fracture (VCF) post spine- stereotactic radiosurgery (SRS) for spinal metastases has been reported in the range of 10-39%. Lesion location, radiological appearance, presence of deformity, mechanical pain and percent of vertebral body involvement has reported as potential predictors of VCF. We report our pilot experience and retrospective analysis of patients thought to be at high risk of progressive VCF who were stabilized prophylactically with a percutaneous technique followed by spine SRS.